A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.
Brief Therapies for Problem Gambling Substance Abusers
Study for Early Detection of Drug Interactions in Older Hospitalized Patients Using on Line Software
Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
Atrial Fibrillation After Cardiac Surgery-comparing Conventional and Miniaturized Bypass Systems
Parental Education on Passive Smoke Exposure and Respiratory Diseases in Infants
Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
† Indicates status has not been verified in more than two years